Morning, and thank you for joining us. This is Kevin Miller, Chief Financial Officer of RCM Technologies. I am joined today by Bradley Vizi, RCM's Executive Chairman. Our presentation in this call will contain forward-looking statements. The information contained in the forward-looking statements is based on our beliefs, estimates, assumptions, and information currently available to us, and these matters may materially change in the future. Many of these beliefs, estimates, and assumptions are subject to rapid change. For more information on our forward-looking statements and the risks, uncertainties, and other factors to which they are subject, please see the periodic reports on Forms 10-K, 10-Q, and 8-K that we file with the SEC, as well as our press releases that we issue from time to time. I will now turn the call over to Bradley Vizi, Executive Chairman, to provide an overview of RCM's operating performance during the second quarter. Thanks, Kevin. Good morning, everyone. Second quarter growth was led by engineering, as project activity continues to ramp, building on the foundation carefully laid over the last several years. More important, engineering's leadership corroborates a fundamental aspect of the RCM thesis. The success of our company is not predicated on any one division or discipline. In 2022, performance was propelled by the success of healthcare. In 2023, life sciences data and solutions were a key pillar to maintaining the company's trajectory, completing the transition to a post-COVID world. And now, in 2024, we are witnessing the emergence of a world-class engineering division with the infrastructure to scale. Five years ago, we presented RCM not as a healthcare company, not as an IT practice, nor an engineering outfit, but an emerging world-class professional services firm that can compete and win on the global stage. That was the vision then, and this is our reality today. Also of note, we anticipate continued strong contribution from engineering, along with increased strength in the other two divisions in the back half of the year. Now, I will provide a more granular update on the progress of each of our teams, starting with Healthcare. RCM's Healthcare division finished the school year strong. Looking ahead to the 2024-2025 school year, we are extremely encouraged about our prospects. We have successfully added many new school districts to our portfolio, several potentially requiring 50-75 new providers. While the exact value of these districts is yet to be determined, RCM has a proven track record of entering new districts and quickly becoming the primary vendor. Our dedicated team is working tirelessly to streamline our recruiting and credentialing processes, reducing time it takes to bring new providers on board and into the field. This commitment to efficiency is not the cost of quality, but to ensure that we can meet the growing demand swiftly and maintain a high standard of service our clients expect. In addition to our domestic growth, we have significantly expanded our operations in the Philippines. This expansion includes not only increasing our recruitment team, but also building a robust operational support team. Investments in both our domestic and international operations, coupled with our unwavering commitment to efficiency and high standards, position us strongly for continued growth and success. We are not just hopeful, but confident that our efforts will drive significant value for our stakeholders as we continue to expand our footprint and enhance our service offerings. In Life Sciences, Data and Solutions, the second quarter showed continued progress as we implemented our solutions integrated approach. We have seen a structural profitability increase relative to the historic performance and work to continue to strengthen the business. We believe our HCM practice is one of the premier partners in the industry. For the eighth straight quarter, we have exceeded implementation quotas for one strategic client. In Life Sciences, our Puerto Rico team just completed a successful 9-month, 15-person quality control project for a major pharma packaging company. Our Life Sciences commercial practice leads our growth as it continues to demonstrate its ability to assist clients to bring new products to market faster, cheaper, while improving compliance reporting. We continue to see strong interest in our managed service offerings. We can support a broad, broad range of functions, ranging from our industry-leading RPC to quality, to validation and qualification, to application support. Transitioning to engineering, starting with Energy Services. Second quarter of 2024 demonstrated robust results, delivering revenue and EBITDA figures exceeding forecasts. Backlog remains solid and activity is healthy as we continue to execute against large engineering substation projects while maintaining high levels of client satisfaction. The EPC group maintains strong relations with existing clients, but also targeted additional potential customers for new projects in the U.S., including Puerto Rico. To participate in the growing energy markets internationally, Energy Services is evaluating cooperation agreements in LATAM and Europe. The German office sees a significant increase in high voltage substation demand and has begun staffing to prepare for further growth. Increasing our market awareness, Energy Services continued a strong presence in most significant technical associations during-... The IEEE events in Puerto Rico and Anaheim, California, becoming a major contributor in the electrical engineering industry. For the upcoming CIGRE Paris session this August, Energy Services will present, together with a large U.S. utility, an innovative technical paper on a future-oriented microgrid substation. In Process & Industrial, RCM Thermal Kinetics remains active in the zero carbon chemical production market, with three equipment projects in various stages of completion. The Thermal Kinetics office is also executing two ethanol plant optimization expansion studies that integrate the patented energy integration design, enabling clients to lower their carbon intensity score. The team is also completing a detailed process design for a planned SAF facility for a U.S.-based customer. Various tests are being conducted for our customers, utilizing test rigs for crystallization, filtration, and evaporation. The sales team is focused on the current market needs and has strategically pursued business in the lithium markets. That focus has yielded an engineering order placement this week for a lithium production facility in the United States. The engineering order involves the development of the lithium solution, chemistry, and processing equipment design. The team also expects to close an equipment order for lithium refinement, which employs crystallization technology and downstream drying of crystals. This project is a good example of the strength of the TK team and the supporting test center. The theoretical chemistry used in the lithium solution chemistry is complex and is de-risked by running the process in the test center with the chemical engineers who are designing the plant. The test center continues to gain momentum and is at 100% utilization through Q2 and well into Q3 2024. We continually evaluate further investment in additional equipment for the test center that benefits our clients. RCM Thermal Kinetics recently presented at the Fuel Ethanol Workshop Trade Show in June. The focus, again, was plant optimization and identifying areas of improvement that our engineers excel at. The team remains focused on the continuation of our emergence as a market leader in responsible and sustainable chemical process design. The Aerospace and Defense Group had mixed results in Q2 2024, due to a slower than anticipated recovery in the aftermarket. However, EBITDA for the division remains healthy. The engineering business is thriving, executing with three more new clients in Q2 of 2024. Our estimate of realizing a healthy increase in EBITDA for 2024 holds true, and the overall strategy remains the same, recognizing most of our customers spend in the engineering domain. RFIs, RFQs, and MSAs expected to finalize have begun to produce new revenue in Q2 with an aggressive increase in headcount. Revenue and profit anticipated to escalate in the second half of 2024. The most significant piece of the business that has had immediate impact is in the engineering arena, with one of our new vertical with customers, our current space customers, as well as our expansion into other divisions with one of our existing aerospace component manufacturers. We have realized much anticipated increases in customer requirements in Q2. Our world-class recruitment team continues to successfully execute, which has allowed us to experience a noteworthy increase in new hires. We have experienced a 54% increase in new hires in Q2 2024 versus Q1 2024. We expect to see this increase quarter-over-quarter in Q3 and Q4. We continue to drive and expand our model-based expertise, software systems, mechanical and avionics expertise throughout the customer base in Q2 2024, with continuous inquiries and partnership opportunities as well. Our new service offering, involving solving quality and production issues within the supply base of our clients, continues to grow with interest. New statements of work with major OEMs have been received with expanded skills and scheduled starts in Q3, Q4 2024, and Q1 2025. We will continue to expand our reach with these clients and prioritize these engagements throughout 2024 and 2025. We have received 3 large RFQs for engineering and aftermarkets within our OEM client base, and with a potential new client in the air mobility arena. The outlook for the second half of 2024 is bright. Now, I will return the call to Kevin to discuss the Q2 2024 financial results in more detail. Thank you, Brad. Regarding our consolidated results, consolidated gross profit for the second quarter of 2024 grew by 6.6% as compared to 2023, from $18.8 million - $20.0 million. Adjusted EBITDA for the second quarter grew by 10.8% from $6.5 million- $7.2 million. Adjusted diluted EPS for the second quarter of 2024 grew by 12.0% from $0.50 - $0.56. As for our segment performance, in the first quarter of 2024, engineering gross profit grew by 23.7%. Life Sciences Data and Solutions gross profit decreased by 17.9%. Healthcare second quarter gross profit grew by 8.6%. If we remove the impact of COVID from the comparable second quarter of 2023, we estimate that second quarter 2024 revenue grew by about 11.1%. If we remove the impact of COVID and the deliberate reduction in services to a large, long time, but slow paying rehab customer, we estimate that second quarter 2024 grew by about 19.1%. School revenue of $30.8 million for the second quarter of 2024 grew by 23.0% after removing COVID revenue from the second quarter of 2023. While we certainly consider our non-school revenue important for our future growth, our healthcare business is largely a school-based healthcare delivery model. Our year-to-date 2024 school revenue in 2024 exceeds 83%. The 2023-2024 school year is the third school year since schools returned from virtual school. The 2023-2024 school year is also the first school year to comprise zero COVID-related revenue. We see some exciting trends. 2023-2024 revenue of $109.8 million grew by 24.9% over 2022-2023, after removing COVID-related revenue from the prior school year. Our non-COVID school revenue in 2022-2023 grew by 29.2% over 2021-2022. School revenue from the last pre-COVID year of 2018-2019 was $60.2 million, which we nearly doubled in 2023-2024. We now have 15 school districts that exceed $500K in revenue. In 2018-2019, we had three. For 2021-2022, we had five. We are optimistic we'll get this well over 20 school districts that exceed $500K for the 2024/2025 school year that begins in August, September of this year, as our new school pipeline is the best it's ever been heading into a new school year. While we often don't know in July, August, if a new school client will generate $50K or $500K in revenue, what I can say is that we've signed far more new school contracts for 2024/2025 than we have at any time in our long history serving school districts. As for the second half of fiscal 2024, we are optimistic that we will continue to see low double-digit consolidated adjusted EBITDA growth as compared to fiscal 2023, with a similar quarterly cadence when compared to fiscal 2023. This concludes our prepared remarks. At this time, we will open the call for questions. Yes, and with that, ladies and gentlemen, please press star one on your telephone keypad if you would like to join the question queue. That is star one on your telephone keypad to join the question queue. All right, first up, we have Alex Rygiel, B. Riley Securities. Thank you, Brad and Kevin. Very solid quarter. Nice to see. Thank you. Thank you. Yeah. Couple quick questions here. First, schools business, obviously, it's doing fantastic. But the strength in the schools business and the commentary, with regards to engineering and other segments, it all seems very bullish and more bullish than, low double digit EBITDA growth. So I wanted to talk to you a little bit about, you know, maybe helping us to understand that, what I feel is maybe a conservative target. Well, just bear in mind, you know, we're talking about Q3 and Q4 of this year. You know, a lot of that, you know, revenue is sort of already baked, right? The schools don't really get going until sort of like, the second week in September. I mean, they, they kind of sprinkle in to August and into September. And we often don't know, you know, how strong they're gonna start in terms of the new schools, and even some of the longtime clients sometimes start a little slow and then ramp up. So it's, it's, you know, we're very bullish on the school year in general, but, you know, we, we have some... If, if, if you look at the numbers, you know, compared to 2023, we had a pretty big jump in Q4 from Q3, right? So, you know, basically predicting sort of a 10%-ish, you know, increase in EBITDA is already baking in a pretty nice, you know, increase in terms of the, the sequential, you know, the sequential movement of revenue and, and EBITDA. But yeah, I mean, we are being a little bit conservative, but that's, you know, by design, because obviously, you know, things can change pretty rapidly, and we don't wanna put big numbers out there, obviously. Brad, as you think about sort of the next 12 months, from a revenue standpoint, which segment do you think grows the fastest? Well, no, that's an interesting question. You know, look, we think about the business every single day, so we can set, you know, work with the team leaders to help set that business up for success. T+2, T+3, and well into the future. So, you know, naturally, when you look at, you know, the strength of all three of these businesses, right? You know, being able to underwrite, you know, the success relative to one another over the short term, right? Based on, drivers that, you know, were invested in and put in place, you know, two, three, you know, potentially two, three years ago, right? It can become difficult from an underwriting perspective. However, I think that this emphasizes a really key point, you know, quite a bit of confidence can be gained in the platform, right? This collection of businesses that was built up, right? When you think about the underwriting of outcomes, both short and long term. But when you isolate any one of the divisions over a short period of time, right, inevitably there could be some gyration, you know, that that's expected and frankly unexpected. So, you know, sorry if it's a little bit too much or not enough, Alex, but I hope that answers your question. And lastly, balance sheet's pretty strong, so quick thoughts on capital allocation priorities. Yeah, look, you know, we've always tried to play this down the middle and, you know, just be very open-minded and flexible and be in a position to move opportunistically. So not necessarily manage the balance sheet to any one quote, optimal capital structure, right? But to be nimble and flexible, right? And be in a position to also, you know, manage our risk profile and keep it relatively low. You know, so, you know, with respect to, you know, share buybacks, obviously, you know, we've been very active over the last several years. You know, well over 40% of the company at this point has been retired. You know, at the same time, you know, opportunities on the M&A front, they continue to be the pipeline continues to strengthen. But we're not gonna deviate from our baseline plan, you know, with respect to evaluating opportunities that we can bolt onto the platform, that we believe we can grow substantially and have an alignment in culture and vision, right, with the existing base. So, you know, we always say one plus one equals five. You know, over, quote, the near term, in terms of the opportunity set, the ones I think are probably most relevant are in engineering, but that can change, too. So, you know, on the capital allocation front, like as you said, we've been pretty consistent, you know, rough under a million, one turn of EBITDA, of leverage. It's not that we're led to that mark, but that seems to be, you know, right where we've things have fallen nicely into place as far as the model. Very helpful. Thank you very much. Nice quarter. Thank you. All right, next up, we have Bill Sutherland of Benchmark. Thanks. Hey, guys. Hey, Brad, you mentioned a 54% increase in new hires, I think for first half, and I guess, I guess just if you could clarify if that's the timeframe and whether it's all of engineering? Yeah, that's aerospace. You know, frankly, you know, aerospace was a little bit more sluggish than we anticipated as a whole, in first half. You know, however, you know, our confidence in the crystallization of that pipeline is improving. So those remarks are relative to aerospace. Okay, thanks. Little dip quarter-over-quarter in, or more pronounced than you usually see in Life Sciences. Is that just project timing? Yeah, good guess. That's a little bit of timing. So, you know, we had a particular high margin project come to an end in Q2 of last year. And, you know, basically what we're backfilling with started a little bit later in Q3. So, you know, we actually think as you get into the back half of Q3 and into Q4, you should see a very healthy uptick in that business. Okay. And when you hear, or maybe Kevin refers to districts, school districts in the pipe, are those ready? I mean, those are signed and just, you know, it's an implementation pipeline or is this a new business plan? So we have a significant number of, you know, of school districts that are signed, you know, over 20 actually. And we think we'll, we're hopeful we'll sign over 30 new school districts heading into next year. And that's a pretty significant... It's a really significant number. Okay. Now, on the flip side, I have to caution you because we just, you know, we get into these schools, and sometimes we're pretty disappointed with the number of recs that we get. Yeah. But we, we've never, you know, been sitting here in July with the number of new school districts that we have for next year. So hopefully we can, you know, penetrate, I don't know, meaningfully 10 of them, maybe more. We'll just, we'll just have to see how it all plays out. But it's, it's a, it's a real exciting time for the healthcare business. Just to be clear, the 20 you've got signed up, or more than 20, that's for the 2024... I'm sorry, for the 2025, 2026 school year? No, for 2024, 2025. They're starting in, you know, August, September. I mean, we're recruiting for some of these schools right now.... Okay. Okay. And the thirty- You're talking about, when I say 24, 25, just to be clear, you're in. And different schools in different parts of the country start at different times. You know, they start anywhere from early August to sort of early September, and they end anywhere from, you know, early May to late June, right? So when you, when I talk about school years, I'm talking about our third and fourth quarter added to our first and second quarter for a school year. Right. Right. Right. And then last, just looking at the cash flow and seeing that second quarter kind of in terms of operating cash flow was pretty much in line with first quarter, should we think about the back half being like the first half? I hope it's better. You know, I hope it's better. I expect, you know, the third quarter should be strong, right? Because, you know, we have a drop in revenue due to seasonality, so that naturally is gonna boost cash flow. Obviously, the revenue spikes back up in Q4, which will hurt cash flow. But, I just, you know, we're working hard to, you know, improve our DSOs in Q4 to sort of offset some of that. So when we look at the second half versus the first half, I expect second half cash flow, you know, when you take Q3 and Q4 and add them together, to be better than Q1 and Q2. I'll be disappointed if it's not. And that's, you know, cash flow from operations, obviously. Okay. Thanks, both. All right. At this time, there are no further questions in queue. I'll remind participants, you can press star one on your telephone keypad if you want to get a last-minute question in. That's star one on your telephone keypad. All right, we did get one more. Frank Kelly, the line is now open. Gentlemen, great quarter. Certainly seems to be on the right, on the right trend. A little bit improvement in, in AR. But, can you shed some light, Kevin, on the SG&A line item? It, year-over-year, it's up over 6% and, revenues obviously are not. But last year, at this time, when we were on the call, we said, "Oh, well, we're investing, we're investing in, you know, infrastructure and, whatnot, and staff." And we've been doing that now, obviously, for the last year. What, what, what drives that additional 6%+ in SG&A, and what are we doing to, to kind of keep us, keep us focused on that? Well, it's, you know, there's really two general drivers of it. Well, three, I would say. One is just, you know, natural inflation of costs, right? If, you know, labor goes up, cost of technology goes up, rent goes up in some areas. So, you know, that's one. Two is we're making a big investment in technology, and particularly cybersecurity is an area where we've had to put a lot of money into it, just to keep up with, you know, making sure our company doesn't get taken down by, you know, cyber threats, right? And there's a lot of money that's been invested in cybersecurity and other IT initiatives. And of course, just investing in infrastructure to support the growth that we expect to come, especially on the healthcare side. I mean, you know, if we overhire a little bit in healthcare, we'll figure it out later, right? But we'll hire as many recruiters in healthcare as we can find, just as an area, and we're continuing, continually investing in SG&A. By the same token, you know, because you've followed the company a long time, you know, we continually look to prune SG&A as well. So we'll continue to look for opportunities to bring... You know, there's certain areas where you just can't bring it down, and you just, you know, like the cost of public being a public company, for instance, has just gone up incredibly over the last couple of years, like, you know, way above, way above double digits. So, you know, but we'll continue to look for opportunities. For instance, you know, Brad mentioned something about opening up an office in the Philippines. And we're gonna continue to leverage some of the talent over there that is a lot cheaper than it is here. So, you know, we'll continue to look to ways to grow our gross profit in an amount that significantly exceeds the growth in SG&A. And that's sort of the way we look at it, Frank. I don't pay attention as much to, you know, the revenue growth relative to SG&A. I look at the growth in, you know, in gross profit versus SG&A. And we can continue to improve that ratio, and we, you know, and we will. Yeah. Also, Frank, Frank, Frank, one thing I'd just add real quick, right? It's, you know, it's starting to think about the company more as, you know, a $500 million company and a $1 billion company, right? So, you know, naturally, when you look at RCM historically, right, you know, the infrastructure, we've under-invested a little bit, frankly, in infrastructure. And, you know, that was in our existing state. Now, when you start to think forward, right, towards building a much larger company, an international company, right, inevitably, you know, in addition to catching up on some of that investment, right, you know, that brings a whole another profile of infrastructure. And, you know, look, the good news is, you know, it's well underway. You know, as always, we're measured and thoughtful about, you know, how we add dollars into our cost structure. So, you know, so far, so good, right? And as revenue growth and GP accelerate, naturally, the fall through should as well. ... Right. Great, understood. And, you know, things like bricks and mortar spot locations that are, you know, becoming more and more unnecessary at this point. I'm sure we're looking at those as well to kind of bring down some of that expensive SG&A. For sure. But our bricks and mortar costs have come down over the last couple years, Frank, which is obviously not gonna be a surprise to you. But we do think that depending on the business, having bricks and mortar is really important. We don't need the same amount of space on a, like, per square foot per person that we needed, you know, 6, 7 years ago. But, you know, we still think it's really important to have bricks and mortar space for people to come to the office, you know, a couple days a week. And again, it depends on the business. There's some businesses that we have that are pretty much, you know, 95% remote, and there's others that aren't. But we'd like to have space where our employees want to come to work, and they want to collaborate, and they want to learn, and they want to get trained. You know, it's important to us to have that space. So we're- Great. We're not, you know, we're not ever gonna move to, you know, a fully remote company, but we're always looking to, you know, to keep those costs down. You know, I love subleases, and we have a couple of those, that are pretty cheap and, you know, and we just continue to look to drive those costs down any way we can. Yeah, yeah, Frank, next time you're in Pennsauken, why don't you stop by HQ and you'll feel pretty good about, you know, the leases that we're investing in? You know, and when you think about, you know, some of our higher leases, right, they tend to resemble more training centers, being much more functional. You know, as you walk through the facilities, you know, it's pretty clear that there's an ROI associated with those investments.